Overview
Samuel Ash is an Intensive Care Medicine provider practicing medicine in South Weymouth, Massachusetts. He has been practicing medicine for over 17 years.
Dr. Ash is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Emphysema, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Chronic Obstructive Pulmonary Disease (COPD).
He is actively involved in clinical research, co-authoring 62 peer reviewed articles.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
Locations
55 Fogg Rd, South Weymouth, MA 02190
75 Francis St, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award. Dr. Silverman is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, and Pulmonary Fibrosis.
Massachusetts General Hospital
Erik Folch is an Intensive Care Medicine provider practicing medicine in Boston, Massachusetts. Dr. Folch is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Tracheobronchomalacia, Advanced Bronchoscopy, and Endoscopy.
Beth Israel Deaconess Medical Center
Robert Hallowell is an Intensive Care Medicine provider practicing medicine in Boston, Massachusetts. Dr. Hallowell is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, and Lung Metastases.
Frequently Asked Questions about Dr. Samuel Ash
How do I make an appointment with Dr. Samuel Ash?
You can book an appointment with Dr. Samuel Ash by calling their office at 781-624-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Samuel Ash a top-rated expert for Emphysema?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samuel Ash is classified as an Distinguished expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Samuel Ash specialize in?
While Dr. Samuel Ash is a Intensive Care Medicine, they have specific expertise in Emphysema, Acute Interstitial Pneumonia, and Interstitial Lung Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Samuel Ash participate in research or clinical trials?
Yes. Dr. Samuel Ash has published 62 articles and abstracts on conditions like Emphysema. You can view a list of Dr. Samuel Ash's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Samuel Ash accept my insurance?
Dr. Samuel Ash accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 781-624-8000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EmphysemaDr. Ash isDistinguished. Learn about Emphysema.
- Advanced
- Acute Interstitial Pneumonia
- Chronic Obstructive Pulmonary Disease (COPD)
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung DiseaseDr. Ash isAdvanced. Learn about Interstitial Lung Disease.
- Pulmonary FibrosisDr. Ash isAdvanced. Learn about Pulmonary Fibrosis.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- AsthmaDr. Ash isExperienced. Learn about Asthma.
- Bronchiolitis ObliteransDr. Ash isExperienced. Learn about Bronchiolitis Obliterans.
- Cerebral HypoxiaDr. Ash isExperienced. Learn about Cerebral Hypoxia.
- PneumoniaDr. Ash isExperienced. Learn about Pneumonia.
- Pulmonary Veno-Occlusive DiseaseDr. Ash isExperienced. Learn about Pulmonary Veno-Occlusive Disease.